HIV/AIDS

A new study suggests that cells engineered by a UCLA-led team have the potential to provide long-term immunity against the virus that causes AIDS.

There is no drug or vaccine to treat or prevent KSHV, which causes cancer, but the researchers showed that an inhibitor could be developed to break it down.

Protein-imaging method developed by new UCLA researcher overcomes challenges of current techniques, offering untold potential in the exploration of disease and treatment.

Williams Institute and Los Angeles HIV Law and Policy Project members drive passage of California Senate Bill 239.

The researchers believe this to be the first national study comparing statin use in patients with and without HIV and the first extensive analysis using U.S. data.

A team of researchers from the UCLA Center for AIDS Research, Stanford University and the National Institutes of Health developed a synthetic molecule that could awaken dormant virus cells and then knock them out.

The National Institute of Drug Abuse grant will go toward developing a resource and data center for use among researchers across the U.S. and Canada.

The research also found that women who had gonorrhea when they gave birth were nearly 20 times more likely to pass on CMV to their babies.

Researchers from seven institutions are studying the well-being of adolescents and young adults with the virus or at risk for infection.

Study from UCLA and other research partners suggests more data collections in conjunction with increasing access to immunizations.

The researchers concluded that the UNAIDS approach would not be practical because it would require finding and treating a very large number of people in remote areas.

UCLA and the Los Angeles LGBT Center have developed a risk calculator that could help men who have sex with men decide whether to take pre-exposure prophylaxis.

The project supports interdisciplinary teams in their work to identify and test approaches for curing people infected with HIV who have established latent reservoirs of the virus.

UCLA's Dr. Roger Detels is recognized for his contributions to controlling HIV/AIDS in China.

Artificial receptors kill cells infected with the virus that causes AIDS, UCLA research finds.

Many midlife and older gay men experience the stress of being part of a sexual minority group. They perceive that they need to conceal their sexual orientation, or that others are uncomfortable with or avoid them because they are gay.

The researchers chalk up Denmark’s success to many factors, including the country’s universal health care system and the availability of free treatment for all people who have been infected with HIV.

The finding could be a cause for concern because many countries rely on the agency to help pay for vital health care services for people with the diseases.

The State Bar of California honored the UCLA Williams Institute's Los Angeles HIV Law and Policy Project with a Pro Bono Service Award.

The findings strongly suggest that stem cell-based gene therapy with a chimeric antigen receptor may be an effective treatment for chronic HIV infection in humans.

New study suggests cocaine makes people significantly more susceptible to HIV infection.

New research might explain why people with HIV develop age-related illnesses about 14 years before their peers who do not have the virus.

The study provides the most detailed information to date about the timing of the immune system’s recovery in school-age children with HIV.

New UCLA research indicates that use of social media such as Facebook and Twitter along with behavioral psychology can boost HIV testing rates, suggesting a valuable tool in the fight against the virus that causes AIDS.

Researchers at UCLA have devised a plan they say would be much more effective in reducing HIV transmission than simply trying to distribute antiretroviral drugs to as many people as possible.